ESC Premium Access

Prevalence of appropriate treatment in elderly heart failure patients and impact on clinical outcomes: a subgroup analysis from REPOSI registry

Congress Presentation

About the speaker

Associate Professor Marco Proietti

University of Milan, Milan (Italy)
11 presentations
0 follower

9 more presentations in this session

Diffuse coronary artery disease and effect of implantable cardioverter-defibrillators in patients with non-ischaemic systolic heart failure

Speaker: Doctor C. Byrne (Copenhagen, DK)

Thumbnail

Predicting cardiac recovery before durable left ventricular assist device implantation in advanced heart failure patients

Speaker: Doctor S. Drakos (Salt Lake City, US)

Thumbnail

Early benefits of empagliflozin in patients with type 2 diabetes with heart failure are not offset by increased adverse events: results from the EMPA-REG OUTCOME trial

Speaker: Doctor P. Pellicori (Glasgow, GB)

Thumbnail

Incidence and prognostic impact of new-onset left bundle branch block in patients with heart failure and reduced ejection fraction

Speaker: Professor L. Kober (Copenhagen, DK)

Thumbnail

Improved attitudes of non-cardiologists towards decreased left ventricular ejection fraction after marking "warning" on echocardiography report

Speaker: Miss Q. Chen (Chengdu, CN)

Thumbnail

Access the full session

Poster Session 3 - Heart failure: prognosis, outcome

Speakers: Associate Professor M. Proietti, Doctor C. Byrne, Doctor S. Drakos, Doctor P. Pellicori, Professor L. Kober...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb